---
title: Ascend vs Oxford Biomedica
slug_a: ascend-adv
slug_b: oxb
site: cdmo
review_signal_gate: closed
canonical_path: /compare/ascend-adv/oxb
generated_by: BioBM Editorial AI
---

# Ascend vs Oxford Biomedica

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Ascend (ascend-adv) is listed for cdmo. Ascend is a gene-to-GMP development partner specializing in advanced biologics and vaccines with 60+ years of custom biologics expertise and 20+ years of AAV development capability. The company offers onsite fill-finish capabilities across multiple US locations and combines next-generation technologies with deep regulatory acumen.

Services: 8. Modalities: 3. Indications: 2. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Oxford Biomedica (oxb) is listed for cdmo. Global viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs.

Services: 12. Modalities: 4. Indications: 3. Locations: 17. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (17).

Review summary: Review summary withheld until site-level review gate opens.